TrialThe oncologist2019
A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus
Gregory L Beatty et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this paperpooled itcites it
TrialThe oncologist2019
Gregory L Beatty et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.